Torsemide, Dapagliflozin FDC not rational: CDSCO Panel Rejects Syngene's Proposal for BA/BE study Dr. Divya Colin25 Sept 2024 6:00 PM ISTNew Delhi: Noting the proposed fixed-dose combination (FDC) of 24 mg extended-release (ER) Torsemide and 8 mg Dapagliflozin Tablets is not rational;...
Neuropathy Impact on Outcomes and Efficacy in HF Patients with Type 2 Diabetes: Insights from DAPA-HF and DELIVER Trials Dr.Niharika Harsha B23 Sept 2024 8:45 AM ISTNew research found that Dapagliflozin reduces the relative and absolute risk of death and heart failure-related hospitalization due to diabetic...
Dapagliflozin Enhances Glycemic Control When Added to Evogliptin and Metformin in Type 2 Diabetes Patients: Study Medha Baranwal13 Sept 2024 9:45 AM ISTKorea: A recent randomized, double-blind, placebo-controlled study has revealed promising results for adding dapagliflozin to an existing regimen of...
Micro Labs Launches Linapride DM: Affordable Diabetes Treatment in India MD Brand Connect2 Sept 2024 12:48 PM ISTUncontrolled Diabetes has become a major challenge in today's Diabetes Management and it keeps raising the bar. As per the ICMR-INDIAB Study...
Breakthrough combo therapy for type 1 diabetes: SGLT2 inhibitors + GRAs boost control, cut insulin use, study reveals Medha Baranwal20 Aug 2024 8:30 AM ISTUSA: In a significant development for treating Type 1 diabetes (T1D), researchers have conducted a randomized clinical trial testing a combination...
Dapagliflozin Enhances Right Ventricular Function in Heart Failure Patients, shows study Medha Baranwal27 July 2024 9:30 AM ISTUSA: Dapagliflozin enhances right ventricular pulsatile afterload and myocardial performance during exercise, which correlates with a reduction in...
Add on dapagliflozin may attenuate fluid retention caused by high doses of zibotentan in CKD: Study Dr. Shravani Dali18 July 2024 3:15 AM ISTAdd-on dapagliflozin may attenuate fluid retention caused by high doses of zibotentan in CKD suggests a study published in the Journal of the American...
Dapagliflozin Linagliptin FDC Superior to Dapagliflozin Vildagliptin FDC in T2DM: Latest Indian Study Dr. Kamal Kant Kohli13 July 2024 11:00 AM ISTDapagliflozin and linagliptin fixed-dose combination (FDC) is superior to dapagliflozin and vildagliptin combination therapy in controlling Hba1c,...
Triple Combination Therapy Effective for Drug-Naive Type 2 Diabetes Patients, shows new Study Medha Baranwal11 July 2024 10:00 AM ISTKorea: A study has demonstrated that initiating treatment with a triple combination therapy (TCT) comprising metformin, dapagliflozin, and saxagliptin...
Sun Pharma Laboratories Gets CDSCO Panel Nod To study Antidiabetic FDC Drug Dr. Divya Colin28 Jun 2024 6:00 PM ISTNew Delhi: The drug major Sun Pharma Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
FDA extends approval of dapagliflozin to Childers for treatment of type 2 diabetes Dr. Kamal Kant Kohli19 Jun 2024 8:00 PM ISTThe US food and Drug Administration has approved dapagliflozin for treatment of children and adolescents with type 2 diabetes as an add-on treatment...
Dapagliflozin fails to improve outcomes in critically ill patients with acute organ dysfunction: DEFENDER Trial findings Medha Baranwal17 Jun 2024 9:00 AM ISTBrazil: In a groundbreaking development for critical care medicine, the DEFENDER trial has unveiled results regarding the use of dapagliflozin in...
